Table 1.

Demographics of study group in pegfilgrastim and filgrastim arm

	Filgrastim (n = 110)	Pegfilgrastim (n = 85)	p value
Age (years)	40 (36%)	44 (51%)	0.09
Gender
Male	80 (72%)	56 (66%)	0.382
Female	30 (28%)	29 (34%)
Disease treated
Multiple myeloma	46 (41%)	45 (54%)	0.37
Hodgkins lymphoma	32 (30%)	21 (25%)
Non-Hodgkins Lymphoma	20 (19%)	14 (16%)
Others	4 (3%)	2 (2.5%)
Acute Leukemia	8 (7%)	2 (2.5%)
Median CD34 106/kg (range)	3.2	3.3	0.82